Biocon Limited (NSE:BIOCON)
India
· Delayed Price · Currency is INR 340.90
-4.65 (-1.35%)
Mar 28, 2025, 3:29 PM IST
Biocon Revenue
Biocon had revenue of 38.21B INR in the quarter ending December 31, 2024, a decrease of -3.35%. This brings the company's revenue in the last twelve months to 147.62B, up 1.02% year-over-year. In the fiscal year ending March 31, 2024, Biocon had annual revenue of 147.56B with 32.05% growth.
Revenue (ttm)
147.62B
Revenue Growth
+1.02%
P/S Ratio
2.77
Revenue / Employee
9.05M
Employees
16,315
Market Cap
408.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
| Mar 31, 2020 | 63.01B | 7.86B | 14.26% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Biocon News
- 4 days ago - Kiran Mazumdar Shaw Compares Bengaluru To Ecuador's Well-Designed Streets: "Hang Your Head In Shame" - NDTV
- 7 days ago - Biocon stock in focus today: Biocon Pharma gets US FDA nod for norepinephrine injection - Business Upturn
- 21 days ago - Stocks to watch today, March 10: Sun Pharma, ONGC, JSW Steel, Biocon, Omaxe and more - Business Upturn
- 24 days ago - Stocks to watch today: TCS, IndiGo, BEL, Biocon, JSW Energy in Focus; Bajaj Finserv, Ola Electric, Go Fashion Decline on March 7, 2025 - Business Upturn
- 24 days ago - Stocks to Watch today: Kalpataru Projects, Bharat Electronics, Biocon, RVNL, Brigade, IndiGo, Power Grid in focus on March 7, 2025 - Business Upturn
- 26 days ago - Stocks to watch today: Power Grid, ONGC, Adani Wilmar, Biocon, Apollo Hospitals, JSW Energy among stocks in focus on March 5, 2025 - Business Upturn
- 27 days ago - Biocon Pharma secures US FDA approvals for Lenalidomide, Dasatinib, and Rivaroxaban tablets - Business Upturn
- 4 weeks ago - Pharma Stocks: Glenmark down 2.43%, Divi’s Lab slips 2.10%, Biocon drops 2.57%, Glaxo plunges 3.44%, Nifty down 1.22% - Business Upturn